Blue Jet Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2025. Further, the company has informed the Exchange regarding voting results.
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Blue Jet Healthcare held its 57th Annual General Meeting on September 26, 2025, via video conferencing, with shareholders passing all six ordinary resolutions. Out of 81,520 shareholders on record, about 82.55% of total shares (143.2 million out of 173.5 million) participated in the voting. Key resolutions included adoption of FY25 audited financial statements, declaration of a dividend of Rs. 1.20 per share, and re-appointment of director Mr. Akshay Arora (retiring by rotation). Shareholders also approved the re-appointment of Mr. Naresh Shah as Whole-Time Director for five years (Dec 2025–Dec 2030) and the re-designation of Mr. Popat Kedar as Whole-Time Director for five years (Sep 2025–Sep 2030). M/s Mehta & Mehta was appointed as Secretarial Auditors for five years (FY26–FY30).
All resolutions passed with overwhelming support (over 99.8% in favour on most items), reflecting strong shareholder confidence. The Rs. 1.20 per share dividend is now confirmed, and board continuity is secured with key director appointments. No material negative signals for shareholders.